As colleagues at the Max Planck Society, Dr. Peter Seeberger, Director of the Max Planck Institute of Colloids and Interfaces, and Dr. Andreas Seidel-Morgenstern, Director of the Max-Planck Institute for Dynamics of Complex Technical Systems both enjoy the autonomy to pursue research topics of their choice. In 2015, the two were awarded the Humanity in Science Award by Phenomenex and The Analytical Scientist for their collective, groundbreaking work producing artemisinin, an antimalarial drug.
Driven by curiosity, Dr. Seeberger entered the field of basic research in chemical and biomedical sciences with the goal of venturing into areas that nobody else had ever explored. After completing his Ph.D., Dr. Seeberger became an Assistant Professor at MIT, earned tenure within three years, and is now a professor at Freie Univerität Berlin. Similarly, Dr. Seidel-Morgenstern followed the path of his own curiosity. Prior to his role at MPI, he received his training in chemical engineering and is also currently a professor of Chemical Process Engineering at the University of Magdeburg.